Will oversee Virginia G. Piper Cancer Center’s internationally recognized Phase I clinical trials programContinue reading
Author Archive: AZBio
GSK Buys Novartis Vaccine Business
GSK announces major 3-part transaction with Novartis to drive sustainable sales growth, improve long-term earnings and deliver increasing returns to shareholdersContinue reading
ASU engineers help make advances in virtual artificial heart implantation
Some firsts in the history of artificial heart implantation are being achieved by an Arizona State University research group and medical professionals at Phoenix Children’s Hospital.Continue reading
A Conversation with Lee Hartwell: ‘This is the era of DNA’
It’s not every day that you get the chance to sit down face-to-face with a Nobel Laureate. But that’s exactly what happened on Tuesday, April 22, 2014, when about 150 Arizona biotechnology movers and shakers shook it up with Leland “Lee” Hartwell, PhD, at the AZBio Leadership Conversation luncheon at the Phoenix Country Club.Continue reading
Dr. AJ Milici appointed Flagship Biosciences’ Head of Biology
Flagship Biosciences announced on April 3, 2014 that Dr. Anthony J. Milici has been appointed Head of Biology. Dr. Milici brings over 30 years of pharmaceutical drug development experience in the areas of neurodegenerative disease, inflammation, and oncology.Continue reading
21-Year-Old Leaves Hospital with a Kidney Saved by the SynCardia Total Artificial Heart
“I was completely shocked,” recalls Tiernee Gonzalez of Ohio. “I found out that it wasn’t the end, that I had another chance at life.”Continue reading
Scientists at the UA Make Critical End-Stage Liver Disease Discovery
The discovery of an unknown cellular pathway has helped scientists and physicians better understand end-stage liver disease and offers a potential target for new therapeutics.Continue reading
Ulthera files for $86M IPO
Ulthera, which sells ultrasound energy systems for the non-invasive lifting of eyebrows and skin around the neck, filed on Monday with the SEC to raise up to $86 million in an initial public offering.Continue reading
Provista Dx announces completion of $6M Series B Financing
Provista Diagnostics, Inc., (Scottsdale, AZ) a privately held molecular diagnostics company developing and commercializing diagnostic, prognostic and predictive tests for cancers affecting women, today announced completion of its Series B financing. The $6.0 million Series B financing was fulfilled by the company’s existing investors.Continue reading
Piper Charitable Trust Announces New President & CEO
The Board of Trustees of Virginia G. Piper Charitable Trust announced today that Dr. Susan M. Pepin, nationally recognized medical educator, clinician, and researcher, will become the next president and CEO of Virginia G. Piper Charitable Trust, effective July 28, 2014.Continue reading